175 related articles for article (PubMed ID: 21475010)
21. Benefit of the measurement of mesorectal extension in patients with pT3N1-2 rectal cancer without pre-operative chemoradiotherapy: Post-operative treatment strategy.
Akagi Y; Shirouzu K; Fujita S; Ueno H; Takii Y; Komori K; Ito M; Sugihara K
Exp Ther Med; 2013 Mar; 5(3):661-666. PubMed ID: 23407463
[TBL] [Abstract][Full Text] [Related]
22. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study.
Taylor FG; Quirke P; Heald RJ; Moran B; Blomqvist L; Swift I; Sebag-Montefiore DJ; Tekkis P; Brown G;
Ann Surg; 2011 Apr; 253(4):711-9. PubMed ID: 21475011
[TBL] [Abstract][Full Text] [Related]
23. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision.
Lee SH; Hernandez de Anda E; Finne CO; Madoff RD; Garcia-Aguilar J
Dis Colon Rectum; 2005 Dec; 48(12):2249-57. PubMed ID: 16400512
[TBL] [Abstract][Full Text] [Related]
24. Oncologic outcomes after resection of rectal cancer: Laparoscopic versus open approach.
Sambasivan CN; Deveney KE; Morris KT
Am J Surg; 2010 May; 199(5):599-603. PubMed ID: 20466102
[TBL] [Abstract][Full Text] [Related]
25. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
[TBL] [Abstract][Full Text] [Related]
26. Laparoscopic versus open surgery for stage I rectal cancer: long-term oncologic outcomes.
Lee SD; Park SC; Park JW; Kim DY; Choi HS; Oh JH
World J Surg; 2013 Mar; 37(3):646-51. PubMed ID: 23188532
[TBL] [Abstract][Full Text] [Related]
27. Time to local recurrence as a prognostic factor in patients with rectal cancer.
Westberg K; Palmer G; Johansson H; Holm T; Martling A
Eur J Surg Oncol; 2015 May; 41(5):659-66. PubMed ID: 25749391
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of extramural vascular invasion in T4 rectal cancer.
Bhangu A; Fitzgerald JE; Slesser A; Northover JM; Faiz O; Tekkis P
Colorectal Dis; 2013 Nov; 15(11):e665-71. PubMed ID: 24103008
[TBL] [Abstract][Full Text] [Related]
29. A novel data-driven prognostic model for staging of colorectal cancer.
Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
[TBL] [Abstract][Full Text] [Related]
30. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
[TBL] [Abstract][Full Text] [Related]
31. Mesorectal grades predict recurrences after curative resection for rectal cancer.
Maslekar S; Sharma A; Macdonald A; Gunn J; Monson JR; Hartley JE
Dis Colon Rectum; 2007 Feb; 50(2):168-75. PubMed ID: 17160574
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcome of anastomosis leakage after curative resection for mid and low rectal cancer.
Chang SC; Lin JK; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2003; 50(54):1898-902. PubMed ID: 14696429
[TBL] [Abstract][Full Text] [Related]
33. Local excision in early rectal cancer-outcome worse than expected: a population based study.
Saraste D; Gunnarsson U; Janson M
Eur J Surg Oncol; 2013 Jun; 39(6):634-9. PubMed ID: 23414776
[TBL] [Abstract][Full Text] [Related]
34. The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision.
Kim YW; Kim NK; Min BS; Lee KY; Sohn SK; Cho CH
Ann Surg; 2009 Jun; 249(6):965-72. PubMed ID: 19474683
[TBL] [Abstract][Full Text] [Related]
35. Preoperative parameters expanding the indication of sphincter preserving surgery in patients with advanced low rectal cancer.
Ueno H; Mochizuki H; Hashiguchi Y; Ishikawa K; Fujimoto H; Shinto E; Hase K
Ann Surg; 2004 Jan; 239(1):34-42. PubMed ID: 14685098
[TBL] [Abstract][Full Text] [Related]
36. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
37. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
[TBL] [Abstract][Full Text] [Related]
38. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
39. Intra-operative perforation is an important predictor of local recurrence and impaired survival after abdominoperineal resection for rectal cancer.
Bülow S; Christensen IJ; Iversen LH; Harling H;
Colorectal Dis; 2011 Nov; 13(11):1256-64. PubMed ID: 20958912
[TBL] [Abstract][Full Text] [Related]
40. Distribution of lymph node metastases is an independent predictor of survival for sigmoid colon and rectal cancer.
Huh JW; Kim YJ; Kim HR
Ann Surg; 2012 Jan; 255(1):70-8. PubMed ID: 22133895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
